mmol mol	0	1.6525	3	For adults with type 2 diabetes managed either by lifestyle and diet, or by lifestyle and diet combined with a single drug not associated with hypoglycaemia, support the person to aim for an HbA1c level of 48 mmol mol(6.5percent).	For adults on a drug associated with hypoglycaemia, support the person to aim for an HbA1c level of 53 mmol mol (7.0percent).	In adults with type 2 diabetes, if HbA1c levels are not adequately controlled by a single drug and rise to 58 mmol mol (7.5percent) or higher: reinforce advice about diet, lifestyle and adherence to drug treatment and support the person to aim for an HbA1c level of 53 mmol mol (7.0percent) and intensify drug treatment.	
foot problems	0	1.5204	1	For guidance on preventing and managing foot problems in adults with type 2 diabetes, see the NICE guideline on diabetic foot problems.	
group education	0	1.5204	1	Offer group education programmes as the preferred option. Provide an alternative of equal standard for a person unable or unwilling to participate in group education.	
kidney disease	1	1.5204	1	For guidance on managing kidney disease in adults with type 2 diabetes, see the NICE guideline on chronic kidney disease in adults.	
low hba1c	0	1.5204	2	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	
renal function	0	1.5204	2	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	
sudden weight	0	1.5204	2	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	
ace inhibitor	0	1.2016	4	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	For a person with continuing intolerance to an ACE inhibitor (other than renal deterioration or hyperkalaemia), substitute an angiotensin II-receptor antagonist for the ACE inhibitor.	Do not combine an ACE inhibitor with an angiotensin II-receptor antagonist to treat hypertension.	If the person's blood pressure is not reduced to the individually agreed target with triple therapy, add an alpha-blocker, a beta-blocker or a potassium-sparing diuretic (the last with caution if the person is already taking an ACE inhibitor or an angiotensin II-receptor antagonist).	
weight loss	0	1.1595	4	For adults with type 2 diabetes who are overweight, set an initial body weight loss target of 5–10percent.	Remember that lesser degrees of weight loss may still be of benefit, and that larger degrees of weight loss in the longer term will have advantageous metabolic impact.	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	
adverse effects	0	1.2035999999999998	2	Check for possible adverse effects of antihypertensive drug treatment – including the risks from unnecessarily low blood pressure.	Encourage them to achieve the target and maintain it unless any resulting adverse effects (including hypoglycaemia), or their efforts to achievetheir target, impair their quality of life.	
cardiovascular disease	0	1.21	2	Do not offer antiplatelet therapy (aspirin or clopidogrel) for adults with type 2 diabetes without cardiovascular disease.	Assess, educate and support men with type 2 diabetes who have problematic erectile dysfunction, addressing contributory factors such as cardiovascular disease as well as possible treatment options.	
caribbean family	0	1.21	2	Exceptions to this are people of African or Caribbean family origin, or women for whom there is a possibility of becoming pregnant.	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	
diabetes care	0	1.21	2	Adopt an individualised approach to diabetes care that is tailored to the needs and circumstances of adults with type 2 diabetes, taking into account their personal preferences, comorbidities, risks from polypharmacy, and their ability to benefit from long-term interventions because of reduced life expectancy.	Explain to people and their carers that structured education is an integral part of diabetes care.	
dietary advice	0	1.21	2	Provide dietary advice in a form sensitive to the person's needs, culture and beliefs, being sensitive to their willingness to change and the effects on their quality of life.	Integrate dietary advice with a personalised diabetes management plan, including other aspects of lifestyle modification, such as increasing physical activity and losing weight.	
family origin	0	1.21	2	Exceptions to this are people of African or Caribbean family origin, or women for whom there is a possibility of becoming pregnant.	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	
glucose levels	0	1.1446999999999998	2	Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless: the person is on insulin or there is evidence of hypoglycaemic episodes or the person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery or the person is pregnant, or is planning to become pregnant.	Consider short-term self-monitoring of blood glucose levels in adults with type 2 diabetes (and review treatment as necessary): when starting treatment with oral or intravenous corticosteroids or to confirm suspected hypoglycaemia.	
phosphodiesterase-5 inhibitor	0	1.21	2	Consider a phosphodiesterase-5 inhibitor to treat problematic erectile dysfunction in men with type 2 diabetes, initially choosing the drug with the lowest acquisition cost and taking into account any contraindications.	Following discussion, refer men with type 2 diabetes to a service offering other medical, surgical or psychological management of erectile dysfunction if treatment (including a phosphodiesterase-5 inhibitor, as appropriate) has been unsuccessful.	
problematic erectile	0	1.21	2	Assess, educate and support men with type 2 diabetes who have problematic erectile dysfunction, addressing contributory factors such as cardiovascular disease as well as possible treatment options.	Consider a phosphodiesterase-5 inhibitor to treat problematic erectile dysfunction in men with type 2 diabetes, initially choosing the drug with the lowest acquisition cost and taking into account any contraindications.	
blood glucose	0	1.0604	3	Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless: the person is on insulin or there is evidence of hypoglycaemic episodes or the person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery or the person is pregnant, or is planning to become pregnant.	Consider short-term self-monitoring of blood glucose levels in adults with type 2 diabetes (and review treatment as necessary): when starting treatment with oral or intravenous corticosteroids or to confirm suspected hypoglycaemia.	Think about a diagnosis of gastroparesis in adults with type 2 diabetes with erratic blood glucose control or unexplained gastric bloating or vomiting, taking into account possible alternative diagnoses.	
hba1c level	0	0.9669000000000001	7	For adults with type 2 diabetes managed either by lifestyle and diet, or by lifestyle and diet combined with a single drug not associated with hypoglycaemia, support the person to aim for an HbA1c level of 48 mmol mol(6.5percent).	For adults on a drug associated with hypoglycaemia, support the person to aim for an HbA1c level of 53 mmol mol (7.0percent).	In adults with type 2 diabetes, if HbA1c levels are not adequately controlled by a single drug and rise to 58 mmol mol (7.5percent) or higher: reinforce advice about diet, lifestyle and adherence to drug treatment and support the person to aim for an HbA1c level of 53 mmol mol (7.0percent) and intensify drug treatment.	If adults with type 2 diabetes achieve an HbA1c level that is lower than their target and they are not experiencing hypoglycaemia, encourage them to maintain it.	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	If adults with type 2 diabetes achieve an HbA1c level that is lower than their target and they are not experiencing hypoglycaemia, encourage them to maintain it.	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	
autonomic neuropathy	0	0.9794999999999999	4	Think about the possibility of autonomic neuropathy affecting the gut in adults with type 2 diabetes who have unexplained diarrhoea that happens particularly at night.	When using tricyclic drugs and antihypertensive drug treatments in adults with type 2 diabetes who have autonomic neuropathy, be aware of the increased likelihood of side effects such as orthostatic hypotension.	Investigate the possibility of autonomic neuropathy affecting the bladder in adults with type 2 diabetes who have unexplained bladder-emptying problems.	In managing autonomic neuropathy symptoms, include specific interventions indicated by the manifestations (for example, for abnormal sweating or nocturnal diarrhoea).	
erectile dysfunction	0	0.9794999999999999	4	Offer men with type 2 diabetes the opportunity to discuss erectile dysfunction as part of their annual review.	Assess, educate and support men with type 2 diabetes who have problematic erectile dysfunction, addressing contributory factors such as cardiovascular disease as well as possible treatment options.	Consider a phosphodiesterase-5 inhibitor to treat problematic erectile dysfunction in men with type 2 diabetes, initially choosing the drug with the lowest acquisition cost and taking into account any contraindications.	Following discussion, refer men with type 2 diabetes to a service offering other medical, surgical or psychological management of erectile dysfunction if treatment (including a phosphodiesterase-5 inhibitor, as appropriate) has been unsuccessful.	
eye screening	0	0.9794999999999999	5	On diagnosis, GPs should immediately refer adults with type 2 diabetes to the local eye screening service.	Arrange repeat structured eye screening annually.	Explain the reasons for, and success of, eye screening systems to adults with type 2 diabetes, so that attendance is not reduced by lack of knowledge or fear of outcome.	Perform visual acuity testing as a routine part of eye screening programmes.	Depending on the findings, follow structured eye screening by: routine review in 1 year or earlier review or referral to an ophthalmologist.	
angiotensin ii-receptor	0	0.9471999999999999	3	For a person with continuing intolerance to an ACE inhibitor (other than renal deterioration or hyperkalaemia), substitute an angiotensin II-receptor antagonist for the ACE inhibitor.	Do not combine an ACE inhibitor with an angiotensin II-receptor antagonist to treat hypertension.	If the person's blood pressure is not reduced to the individually agreed target with triple therapy, add an alpha-blocker, a beta-blocker or a potassium-sparing diuretic (the last with caution if the person is already taking an ACE inhibitor or an angiotensin II-receptor antagonist).	
first-line antihypertensive	0	0.9471999999999999	3	First-line antihypertensive drug treatment should be a once-daily, generic angiotensin-converting enzyme (ACE) inhibitor.	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	A calcium-channel blocker should be the first-line antihypertensive drug treatment for a woman for whom, after an informed discussion, it is agreed there is a possibility of her becoming pregnant	
ii-receptor antagonist	0	0.9471999999999999	3	For a person with continuing intolerance to an ACE inhibitor (other than renal deterioration or hyperkalaemia), substitute an angiotensin II-receptor antagonist for the ACE inhibitor.	Do not combine an ACE inhibitor with an angiotensin II-receptor antagonist to treat hypertension.	If the person's blood pressure is not reduced to the individually agreed target with triple therapy, add an alpha-blocker, a beta-blocker or a potassium-sparing diuretic (the last with caution if the person is already taking an ACE inhibitor or an angiotensin II-receptor antagonist).	
calcium-channel blocker	0	0.8699999999999999	4	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	A calcium-channel blocker should be the first-line antihypertensive drug treatment for a woman for whom, after an informed discussion, it is agreed there is a possibility of her becoming pregnant	If the person's blood pressure is not reduced to the individually agreed target with first-line therapy, add a calcium-channel blocker or a diuretic (usually a thiazide or thiazide-related diuretic).	Add the other drug (that is, the calcium-channel blocker or diuretic) if the target is not reached with dual therapy.	
4–6 months	0	1.1627999999999998	1	Monitor the blood pressure of a person who has attained and consistently remained at his or her blood pressure target every 4–6 months.	
achievetheir target	0	1.2111999999999998	1	Encourage them to achieve the target and maintain it unless any resulting adverse effects (including hypoglycaemia), or their efforts to achievetheir target, impair their quality of life.	
acquisition cost	0	1.2263	1	Consider a phosphodiesterase-5 inhibitor to treat problematic erectile dysfunction in men with type 2 diabetes, initially choosing the drug with the lowest acquisition cost and taking into account any contraindications.	
acuity testing	0	1.2263	1	Perform visual acuity testing as a routine part of eye screening programmes.	
advise adults	0	1.2263	1	Advise adults with type 2 diabetes that limited substitution of sucrose-containing foods for other carbohydrate in the meal plan is allowable, but that they should take care to avoid excess energy intake.	
alcohol intake	0	1.2263	1	Individualise recommendations for carbohydrate and alcohol intake, and meal patterns.	
alternative diagnoses	0	1.2263	1	Think about a diagnosis of gastroparesis in adults with type 2 diabetes with erratic blood glucose control or unexplained gastric bloating or vomiting, taking into account possible alternative diagnoses.	
angiotensin-converting enzyme	0	1.2263	1	First-line antihypertensive drug treatment should be a once-daily, generic angiotensin-converting enzyme (ACE) inhibitor.	
annual reinforcement	0	1.2263	1	Offer structured education to adults with type 2 diabetes and or their family members or carers (as appropriate) at and around the time of diagnosis, with annual reinforcement and review.	
annual review	0	1.2263	1	Offer men with type 2 diabetes the opportunity to discuss erectile dysfunction as part of their annual review.	
antiemetic therapy	0	1.2263	1	For adults with type 2 diabetes who have vomiting caused by gastroparesis, explain that: there is not strong evidence that any available antiemetic therapy is effective some people have had benefit with domperidone11, erythromycin12 or metoclopramide13.	
antiplatelet therapy	0	1.2263	1	Do not offer antiplatelet therapy (aspirin or clopidogrel) for adults with type 2 diabetes without cardiovascular disease.	
arrange emergency	0	1.2263	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
arrange rapid	0	1.2263	1	Arrange rapid review by an ophthalmologist for new vessel formation.	
balanced eating	0	1.2111999999999998	1	Emphasise advice on healthy balanced eating that is applicable to the general population when providing advice to adults with type 2 diabetes.	
bladder-emptying problems	0	1.2263	1	Investigate the possibility of autonomic neuropathy affecting the bladder in adults with type 2 diabetes who have unexplained bladder-emptying problems.	
body weight	0	1.2263	1	For adults with type 2 diabetes who are overweight, set an initial body weight loss target of 5–10percent.	
carbohydrate content	0	1.2263	1	When adults with type 2 diabetes are admitted to hospital as inpatients or to any other care setting, implement a meal planning system that provides consistency in the carbohydrate content of meals and snacks.	
cardiac risk	0	1.2263	1	the strongest evidence for effectiveness is for domperidone11, but prescribers must take into account its safety profile, in particular its cardiac risk and potential interactions with other medicines.	
clinical biochemistry	0	1.2263	1	Seek advice from a team with specialist expertise in diabetes or clinical biochemistry.	
clinical chemistry	0	1.2263	1	Use methods to measure HbA1c that have been calibrated according to International Federation of Clinical Chemistry (IFCC) standardisation.	
contributory factors	0	1.2263	1	Assess, educate and support men with type 2 diabetes who have problematic erectile dysfunction, addressing contributory factors such as cardiovascular disease as well as possible treatment options.	
contributory sympathetic	0	1.2263	1	Think about the possibility of contributory sympathetic nervous system damage for adults with type 2 diabetes who lose the warning signs of hypoglycaemia.	
current drug	0	1.2263	1	Make changes only if there is poor control or if current drug treatment is not appropriate because of microvascular complications or metabolic problems.	
dairy products	0	1.2263	1	Encourage high-fibre, low-glycaemic-index sources of carbohydrate in the diet, such as fruit, vegetables, wholegrains and pulses; include low-fat dairy products and oily fish; and control the intake of foods containing saturated and trans fatty acids.	
diabetes management	0	1.2263	1	Integrate dietary advice with a personalised diabetes management plan, including other aspects of lifestyle modification, such as increasing physical activity and losing weight.	
diabetic peripheral	0	1.2263	1	For guidance on managing painful diabetic peripheral neuropathy in adults with type 2 diabetes, see the NICE guideline on neuropathic pain in adults.	
differential diagnosis	0	1.2263	1	If gastroparesis is suspected, consider referral to specialist services if: the differential diagnosis is in doubt or persistent or severe vomiting occurs.	
digital retinal	0	1.2263	1	Use a quality-assured digital retinal photography programme using appropriately trained staff.	
drug treatments	0	1.2263	1	When using tricyclic drugs and antihypertensive drug treatments in adults with type 2 diabetes who have autonomic neuropathy, be aware of the increased likelihood of side effects such as orthostatic hypotension.	
dual therapy	0	1.2263	1	Add the other drug (that is, the calcium-channel blocker or diuretic) if the target is not reached with dual therapy.	
effective treatment	0	1.2263	1	For treating vomiting caused by gastroparesis in adults with type 2 diabetes: consider alternating use of erythomycin12 and metoclopramide13 consider domperidone11 only in exceptional circumstances (if domperidone is the only effective treatment) and in accordance with MHRA guidance.	
emergency review	0	1.2263	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
emphasise advice	0	1.2111999999999998	1	Emphasise advice on healthy balanced eating that is applicable to the general population when providing advice to adults with type 2 diabetes.	
encourage high-fibre	0	1.2263	1	Encourage high-fibre, low-glycaemic-index sources of carbohydrate in the diet, such as fruit, vegetables, wholegrains and pulses; include low-fat dairy products and oily fish; and control the intake of foods containing saturated and trans fatty acids.	
energy intake	0	1.2263	1	Advise adults with type 2 diabetes that limited substitution of sucrose-containing foods for other carbohydrate in the meal plan is allowable, but that they should take care to avoid excess energy intake.	
erratic blood	0	1.2263	1	Think about a diagnosis of gastroparesis in adults with type 2 diabetes with erratic blood glucose control or unexplained gastric bloating or vomiting, taking into account possible alternative diagnoses.	
exceptional circumstances	0	1.2263	1	For treating vomiting caused by gastroparesis in adults with type 2 diabetes: consider alternating use of erythomycin12 and metoclopramide13 consider domperidone11 only in exceptional circumstances (if domperidone is the only effective treatment) and in accordance with MHRA guidance.	
excess energy	0	1.2263	1	Advise adults with type 2 diabetes that limited substitution of sucrose-containing foods for other carbohydrate in the meal plan is allowable, but that they should take care to avoid excess energy intake.	
fatty acids	0	1.2263	1	Encourage high-fibre, low-glycaemic-index sources of carbohydrate in the diet, such as fruit, vegetables, wholegrains and pulses; include low-fat dairy products and oily fish; and control the intake of foods containing saturated and trans fatty acids.	
first-line therapy	0	1.2263	1	If the person's blood pressure is not reduced to the individually agreed target with first-line therapy, add a calcium-channel blocker or a diuretic (usually a thiazide or thiazide-related diuretic).	
form sensitive	0	1.2263	1	Provide dietary advice in a form sensitive to the person's needs, culture and beliefs, being sensitive to their willingness to change and the effects on their quality of life.	
general population	1	1.2111999999999998	1	Emphasise advice on healthy balanced eating that is applicable to the general population when providing advice to adults with type 2 diabetes.	
generic angiotensin-converting	0	1.2263	1	First-line antihypertensive drug treatment should be a once-daily, generic angiotensin-converting enzyme (ACE) inhibitor.	
generic calcium-channel	0	1.2263	1	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	
glucose control	0	1.2263	1	Think about a diagnosis of gastroparesis in adults with type 2 diabetes with erratic blood glucose control or unexplained gastric bloating or vomiting, taking into account possible alternative diagnoses.	
glucose measurements	0	1.2263	1	Investigate unexplained discrepancies between HbA1c and other glucose measurements.	
haemorrhage retinal	0	1.2263	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
hba1c target	0	1.2263	1	Involve adults with type 2 diabetes in decisions about their individual HbA1c target.	
healthcare professional	0	1.2263	1	Provide individualised and ongoing nutritional advice from a healthcare professional with specific expertise and competencies in nutrition.	
healthy balanced	0	1.2111999999999998	1	Emphasise advice on healthy balanced eating that is applicable to the general population when providing advice to adults with type 2 diabetes.	
hypoglycaemic episodes	0	1.0716999999999999	1	Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless: the person is on insulin or there is evidence of hypoglycaemic episodes or the person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery or the person is pregnant, or is planning to become pregnant.	
individual hba1c	0	1.2263	1	Involve adults with type 2 diabetes in decisions about their individual HbA1c target.	
individualise recommendations	0	1.2263	1	Individualise recommendations for carbohydrate and alcohol intake, and meal patterns.	
initial body	0	1.2263	1	For adults with type 2 diabetes who are overweight, set an initial body weight loss target of 5–10percent.	
integral part	0	1.2263	1	Explain to people and their carers that structured education is an integral part of diabetes care.	
integrate dietary	0	1.2263	1	Integrate dietary advice with a personalised diabetes management plan, including other aspects of lifestyle modification, such as increasing physical activity and losing weight.	
international federation	0	1.2263	1	Use methods to measure HbA1c that have been calibrated according to International Federation of Clinical Chemistry (IFCC) standardisation.	
intravenous corticosteroids	0	1.2263	1	Consider short-term self-monitoring of blood glucose levels in adults with type 2 diabetes (and review treatment as necessary): when starting treatment with oral or intravenous corticosteroids or to confirm suspected hypoglycaemia.	
investigate unexplained	0	1.2263	1	Investigate unexplained discrepancies between HbA1c and other glucose measurements.	
involve adults	0	1.2263	1	Involve adults with type 2 diabetes in decisions about their individual HbA1c target.	
iridis pre-retinal	0	1.2263	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
life expectancy	0	1.2263	1	Adopt an individualised approach to diabetes care that is tailored to the needs and circumstances of adults with type 2 diabetes, taking into account their personal preferences, comorbidities, risks from polypharmacy, and their ability to benefit from long-term interventions because of reduced life expectancy.	
lifestyle modification	0	1.2263	1	Integrate dietary advice with a personalised diabetes management plan, including other aspects of lifestyle modification, such as increasing physical activity and losing weight.	
limited substitution	0	1.2263	1	Advise adults with type 2 diabetes that limited substitution of sucrose-containing foods for other carbohydrate in the meal plan is allowable, but that they should take care to avoid excess energy intake.	
local area	1	1.2263	1	Ensure that the patient-education programmes available meet the cultural, linguistic, cognitive and literacy needs within the local area.	
local eye	0	1.2263	1	On diagnosis, GPs should immediately refer adults with type 2 diabetes to the local eye screening service.	
long-term interventions	0	1.2263	1	Adopt an individualised approach to diabetes care that is tailored to the needs and circumstances of adults with type 2 diabetes, taking into account their personal preferences, comorbidities, risks from polypharmacy, and their ability to benefit from long-term interventions because of reduced life expectancy.	
loss target	0	1.2263	1	For adults with type 2 diabetes who are overweight, set an initial body weight loss target of 5–10percent.	
low blood	0	1.2263	1	Check for possible adverse effects of antihypertensive drug treatment – including the risks from unnecessarily low blood pressure.	
low-fat dairy	0	1.2263	1	Encourage high-fibre, low-glycaemic-index sources of carbohydrate in the diet, such as fruit, vegetables, wholegrains and pulses; include low-fat dairy products and oily fish; and control the intake of foods containing saturated and trans fatty acids.	
low-glycaemic-index sources	0	1.2263	1	Encourage high-fibre, low-glycaemic-index sources of carbohydrate in the diet, such as fruit, vegetables, wholegrains and pulses; include low-fat dairy products and oily fish; and control the intake of foods containing saturated and trans fatty acids.	
management plan	0	1.2263	1	Integrate dietary advice with a personalised diabetes management plan, including other aspects of lifestyle modification, such as increasing physical activity and losing weight.	
meal patterns	0	1.2263	1	Individualise recommendations for carbohydrate and alcohol intake, and meal patterns.	
meal plan	0	1.2263	2	Advise adults with type 2 diabetes that limited substitution of sucrose-containing foods for other carbohydrate in the meal plan is allowable, but that they should take care to avoid excess energy intake.	When adults with type 2 diabetes are admitted to hospital as inpatients or to any other care setting, implement a meal planning system that provides consistency in the carbohydrate content of meals and snacks.	
meal planning	0	1.2263	1	When adults with type 2 diabetes are admitted to hospital as inpatients or to any other care setting, implement a meal planning system that provides consistency in the carbohydrate content of meals and snacks.	
measure blood	0	1.2263	1	Measure blood pressure at least annually in an adult with type 2 diabetes without previously diagnosed hypertension or renal disease.	
metabolic problems	0	1.2263	1	Make changes only if there is poor control or if current drug treatment is not appropriate because of microvascular complications or metabolic problems.	
mhra guidance	0	1.2263	1	For treating vomiting caused by gastroparesis in adults with type 2 diabetes: consider alternating use of erythomycin12 and metoclopramide13 consider domperidone11 only in exceptional circumstances (if domperidone is the only effective treatment) and in accordance with MHRA guidance.	
microvascular complications	0	1.2263	1	Make changes only if there is poor control or if current drug treatment is not appropriate because of microvascular complications or metabolic problems.	
nervous system	0	1.2263	1	Think about the possibility of contributory sympathetic nervous system damage for adults with type 2 diabetes who lose the warning signs of hypoglycaemia.	
neuropathic pain	0	1.2263	1	For guidance on managing painful diabetic peripheral neuropathy in adults with type 2 diabetes, see the NICE guideline on neuropathic pain in adults.	
neuropathy symptoms	0	1.2263	1	In managing autonomic neuropathy symptoms, include specific interventions indicated by the manifestations (for example, for abnormal sweating or nocturnal diarrhoea).	
nocturnal diarrhoea	0	1.2263	1	In managing autonomic neuropathy symptoms, include specific interventions indicated by the manifestations (for example, for abnormal sweating or nocturnal diarrhoea).	
nutritional advice	0	1.2263	1	Provide individualised and ongoing nutritional advice from a healthcare professional with specific expertise and competencies in nutrition.	
offer men	0	1.2263	1	Offer men with type 2 diabetes the opportunity to discuss erectile dysfunction as part of their annual review.	
oily fish	0	1.2263	1	Encourage high-fibre, low-glycaemic-index sources of carbohydrate in the diet, such as fruit, vegetables, wholegrains and pulses; include low-fat dairy products and oily fish; and control the intake of foods containing saturated and trans fatty acids.	
ongoing nutritional	0	1.2263	1	Provide individualised and ongoing nutritional advice from a healthcare professional with specific expertise and competencies in nutrition.	
oral medication	0	1.0716999999999999	1	Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless: the person is on insulin or there is evidence of hypoglycaemic episodes or the person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery or the person is pregnant, or is planning to become pregnant.	
orthostatic hypotension	0	1.2263	1	When using tricyclic drugs and antihypertensive drug treatments in adults with type 2 diabetes who have autonomic neuropathy, be aware of the increased likelihood of side effects such as orthostatic hypotension.	
painful diabetic	0	1.2263	1	For guidance on managing painful diabetic peripheral neuropathy in adults with type 2 diabetes, see the NICE guideline on neuropathic pain in adults.	
perform visual	0	1.2263	1	Perform visual acuity testing as a routine part of eye screening programmes.	
peripheral neuropathy	0	1.2263	1	For guidance on managing painful diabetic peripheral neuropathy in adults with type 2 diabetes, see the NICE guideline on neuropathic pain in adults.	
personal preferences	0	1.2263	1	Adopt an individualised approach to diabetes care that is tailored to the needs and circumstances of adults with type 2 diabetes, taking into account their personal preferences, comorbidities, risks from polypharmacy, and their ability to benefit from long-term interventions because of reduced life expectancy.	
photography programme	0	1.2263	1	Use a quality-assured digital retinal photography programme using appropriately trained staff.	
planning system	0	1.2263	1	When adults with type 2 diabetes are admitted to hospital as inpatients or to any other care setting, implement a meal planning system that provides consistency in the carbohydrate content of meals and snacks.	
poor control	0	1.2263	1	Make changes only if there is poor control or if current drug treatment is not appropriate because of microvascular complications or metabolic problems.	
potassium-sparing diuretic	0	1.2263	1	If the person's blood pressure is not reduced to the individually agreed target with triple therapy, add an alpha-blocker, a beta-blocker or a potassium-sparing diuretic (the last with caution if the person is already taking an ACE inhibitor or an angiotensin II-receptor antagonist).	
potential interactions	0	1.2263	1	the strongest evidence for effectiveness is for domperidone11, but prescribers must take into account its safety profile, in particular its cardiac risk and potential interactions with other medicines.	
pressure control	0	1.2263	1	For an adult with type 2 diabetes on antihypertensive drug treatment when diabetes is diagnosed, review blood pressure control and medications used.	
pressure target	0	1.1627999999999998	1	Monitor the blood pressure of a person who has attained and consistently remained at his or her blood pressure target every 4–6 months.	
preventive lifestyle	0	1.2263	1	Offer and reinforce preventive lifestyle advice.	
psychological management	0	1.2263	1	Following discussion, refer men with type 2 diabetes to a service offering other medical, surgical or psychological management of erectile dysfunction if treatment (including a phosphodiesterase-5 inhibitor, as appropriate) has been unsuccessful.	
quality-assured digital	0	1.2263	1	Use a quality-assured digital retinal photography programme using appropriately trained staff.	
rapid review	0	1.2263	1	Arrange rapid review by an ophthalmologist for new vessel formation.	
renal disease	0	1.2263	1	Measure blood pressure at least annually in an adult with type 2 diabetes without previously diagnosed hypertension or renal disease.	
retinal detachment	0	1.2263	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
retinal photography	0	1.2263	1	Use a quality-assured digital retinal photography programme using appropriately trained staff.	
review treatment	0	1.2263	1	Consider short-term self-monitoring of blood glucose levels in adults with type 2 diabetes (and review treatment as necessary): when starting treatment with oral or intravenous corticosteroids or to confirm suspected hypoglycaemia.	
routine part	0	1.2263	1	Perform visual acuity testing as a routine part of eye screening programmes.	
routine review	0	1.1133	1	Depending on the findings, follow structured eye screening by: routine review in 1 year or earlier review or referral to an ophthalmologist.	
rubeosis iridis	0	1.2263	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
safety profile	0	1.2263	1	the strongest evidence for effectiveness is for domperidone11, but prescribers must take into account its safety profile, in particular its cardiac risk and potential interactions with other medicines.	
screening programmes	0	1.2263	1	Perform visual acuity testing as a routine part of eye screening programmes.	
screening service	0	1.2263	1	On diagnosis, GPs should immediately refer adults with type 2 diabetes to the local eye screening service.	
screening systems	0	1.2263	1	Explain the reasons for, and success of, eye screening systems to adults with type 2 diabetes, so that attendance is not reduced by lack of knowledge or fear of outcome.	
seek advice	0	1.2263	1	Seek advice from a team with specialist expertise in diabetes or clinical biochemistry.	
severe vomiting	0	1.2263	1	If gastroparesis is suspected, consider referral to specialist services if: the differential diagnosis is in doubt or persistent or severe vomiting occurs.	
short-term self-monitoring	0	1.2263	1	Consider short-term self-monitoring of blood glucose levels in adults with type 2 diabetes (and review treatment as necessary): when starting treatment with oral or intravenous corticosteroids or to confirm suspected hypoglycaemia.	
side effects	0	1.2263	1	When using tricyclic drugs and antihypertensive drug treatments in adults with type 2 diabetes who have autonomic neuropathy, be aware of the increased likelihood of side effects such as orthostatic hypotension.	
specialist expertise	0	1.2263	1	Seek advice from a team with specialist expertise in diabetes or clinical biochemistry.	
specialist services	0	1.2263	1	If gastroparesis is suspected, consider referral to specialist services if: the differential diagnosis is in doubt or persistent or severe vomiting occurs.	
specific expertise	0	1.2263	1	Provide individualised and ongoing nutritional advice from a healthcare professional with specific expertise and competencies in nutrition.	
specific interventions	0	1.2263	1	In managing autonomic neuropathy symptoms, include specific interventions indicated by the manifestations (for example, for abnormal sweating or nocturnal diarrhoea).	
strong evidence	0	1.2263	1	For adults with type 2 diabetes who have vomiting caused by gastroparesis, explain that: there is not strong evidence that any available antiemetic therapy is effective some people have had benefit with domperidone11, erythromycin12 or metoclopramide13.	
structured eye	0	1.2263	2	Arrange repeat structured eye screening annually.	Depending on the findings, follow structured eye screening by: routine review in 1 year or earlier review or referral to an ophthalmologist.	
sucrose-containing foods	0	1.2263	1	Advise adults with type 2 diabetes that limited substitution of sucrose-containing foods for other carbohydrate in the meal plan is allowable, but that they should take care to avoid excess energy intake.	
sudden loss	0	1.2263	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
suspected hypoglycaemia	0	1.2263	1	Consider short-term self-monitoring of blood glucose levels in adults with type 2 diabetes (and review treatment as necessary): when starting treatment with oral or intravenous corticosteroids or to confirm suspected hypoglycaemia.	
sympathetic nervous	0	1.2263	1	Think about the possibility of contributory sympathetic nervous system damage for adults with type 2 diabetes who lose the warning signs of hypoglycaemia.	
system damage	0	1.2263	1	Think about the possibility of contributory sympathetic nervous system damage for adults with type 2 diabetes who lose the warning signs of hypoglycaemia.	
thiazide-related diuretic	0	1.2263	1	If the person's blood pressure is not reduced to the individually agreed target with first-line therapy, add a calcium-channel blocker or a diuretic (usually a thiazide or thiazide-related diuretic).	
trained staff	0	1.2263	1	Use a quality-assured digital retinal photography programme using appropriately trained staff.	
trans fatty	0	1.2263	1	Encourage high-fibre, low-glycaemic-index sources of carbohydrate in the diet, such as fruit, vegetables, wholegrains and pulses; include low-fat dairy products and oily fish; and control the intake of foods containing saturated and trans fatty acids.	
treatment options	0	1.2263	1	Assess, educate and support men with type 2 diabetes who have problematic erectile dysfunction, addressing contributory factors such as cardiovascular disease as well as possible treatment options.	
tricyclic drugs	0	1.2263	1	When using tricyclic drugs and antihypertensive drug treatments in adults with type 2 diabetes who have autonomic neuropathy, be aware of the increased likelihood of side effects such as orthostatic hypotension.	
triple therapy	0	1.2263	1	If the person's blood pressure is not reduced to the individually agreed target with triple therapy, add an alpha-blocker, a beta-blocker or a potassium-sparing diuretic (the last with caution if the person is already taking an ACE inhibitor or an angiotensin II-receptor antagonist).	
unexplained bladder-emptying	0	1.2263	1	Investigate the possibility of autonomic neuropathy affecting the bladder in adults with type 2 diabetes who have unexplained bladder-emptying problems.	
unexplained diarrhoea	0	1.2263	1	Think about the possibility of autonomic neuropathy affecting the gut in adults with type 2 diabetes who have unexplained diarrhoea that happens particularly at night.	
unexplained discrepancies	0	1.2263	1	Investigate unexplained discrepancies between HbA1c and other glucose measurements.	
unexplained gastric	0	1.2263	1	Think about a diagnosis of gastroparesis in adults with type 2 diabetes with erratic blood glucose control or unexplained gastric bloating or vomiting, taking into account possible alternative diagnoses.	
vessel formation	0	1.2263	1	Arrange rapid review by an ophthalmologist for new vessel formation.	
vision rubeosis	0	1.2263	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
visual impairment	0	1.2263	1	Take into account any disabilities, including visual impairment, when planning and delivering care for adults with type 2 diabetes.	
vitreous haemorrhage	0	1.2263	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
structured education	0	0.8885	3	Offer structured education to adults with type 2 diabetes and or their family members or carers (as appropriate) at and around the time of diagnosis, with annual reinforcement and review.	Explain to people and their carers that structured education is an integral part of diabetes care.	Ensure that any structured education programme for adults with type 2 diabetes includes the following components: It is evidence-based, and suits the needs of the person. It has specific aims and learning objectives, and supports the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes. It has a structured curriculum that is theory-driven, evidence-based and resource-effective, has supporting materials, and is written down. It is delivered by trained educators who have an understanding of educational theory appropriate to the age and needs of the person, and who are trained and competent to deliver the principles and content of the programme. It is quality assured, and reviewed by trained, competent, independent assessors who measure it against criteria that ensure consistency. The outcomes are audited regularly.	
blood pressure	0	0.6939000000000001	8	Measure blood pressure at least annually in an adult with type 2 diabetes without previously diagnosed hypertension or renal disease.	For an adult with type 2 diabetes on antihypertensive drug treatment when diabetes is diagnosed, review blood pressure control and medications used.	Add medications if lifestyle advice does not reduce blood pressure to below 140 80 mmHg (below 130 80 mmHg if there is kidney, eye or cerebrovascular damage).	Monitor blood pressure every 1–2 months, and intensify therapy if the person is already on antihypertensive drug treatment, until the blood pressure is consistently below 140 80 mmHg (below 130 80 mmHg if there is kidney, eye or cerebrovascular damage).	If the person's blood pressure is not reduced to the individually agreed target with first-line therapy, add a calcium-channel blocker or a diuretic (usually a thiazide or thiazide-related diuretic).	If the person's blood pressure is not reduced to the individually agreed target with triple therapy, add an alpha-blocker, a beta-blocker or a potassium-sparing diuretic (the last with caution if the person is already taking an ACE inhibitor or an angiotensin II-receptor antagonist).	Monitor the blood pressure of a person who has attained and consistently remained at his or her blood pressure target every 4–6 months.	Check for possible adverse effects of antihypertensive drug treatment – including the risks from unnecessarily low blood pressure.	
family members	0	0.694	3	Offer structured education to adults with type 2 diabetes and or their family members or carers (as appropriate) at and around the time of diagnosis, with annual reinforcement and review.	Ensure that any structured education programme for adults with type 2 diabetes includes the following components: It is evidence-based, and suits the needs of the person. It has specific aims and learning objectives, and supports the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes. It has a structured curriculum that is theory-driven, evidence-based and resource-effective, has supporting materials, and is written down. It is delivered by trained educators who have an understanding of educational theory appropriate to the age and needs of the person, and who are trained and competent to deliver the principles and content of the programme. It is quality assured, and reviewed by trained, competent, independent assessors who measure it against criteria that ensure consistency. The outcomes are audited regularly.	Ensure that all members of the diabetes healthcare team are familiar with the patient-education programmes available locally, that these programmes are integrated with the rest of the care pathway, and that adults with type 2 diabetes and their family members or carers (as appropriate) have the opportunity to contribute to the design and provision of local programmes.	
informed discussion	0	0.7768999999999999	1	A calcium-channel blocker should be the first-line antihypertensive drug treatment for a woman for whom, after an informed discussion, it is agreed there is a possibility of her becoming pregnant	
renal deterioration	0	0.7768999999999999	1	For a person with continuing intolerance to an ACE inhibitor (other than renal deterioration or hyperkalaemia), substitute an angiotensin II-receptor antagonist for the ACE inhibitor.	
nice guideline	0	0.5271999999999999	4	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	For guidance on managing painful diabetic peripheral neuropathy in adults with type 2 diabetes, see the NICE guideline on neuropathic pain in adults.	For guidance on preventing and managing foot problems in adults with type 2 diabetes, see the NICE guideline on diabetic foot problems.	For guidance on managing kidney disease in adults with type 2 diabetes, see the NICE guideline on chronic kidney disease in adults.	
antihypertensive drug	0	0.5332	7	For an adult with type 2 diabetes on antihypertensive drug treatment when diabetes is diagnosed, review blood pressure control and medications used.	Monitor blood pressure every 1–2 months, and intensify therapy if the person is already on antihypertensive drug treatment, until the blood pressure is consistently below 140 80 mmHg (below 130 80 mmHg if there is kidney, eye or cerebrovascular damage).	First-line antihypertensive drug treatment should be a once-daily, generic angiotensin-converting enzyme (ACE) inhibitor.	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	A calcium-channel blocker should be the first-line antihypertensive drug treatment for a woman for whom, after an informed discussion, it is agreed there is a possibility of her becoming pregnant	Check for possible adverse effects of antihypertensive drug treatment – including the risks from unnecessarily low blood pressure.	When using tricyclic drugs and antihypertensive drug treatments in adults with type 2 diabetes who have autonomic neuropathy, be aware of the increased likelihood of side effects such as orthostatic hypotension.	
physical activity	0	0.5792999999999999	2	Integrate dietary advice with a personalised diabetes management plan, including other aspects of lifestyle modification, such as increasing physical activity and losing weight.	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	
mmol mol(6.5percent	0	0.6799	1	For adults with type 2 diabetes managed either by lifestyle and diet, or by lifestyle and diet combined with a single drug not associated with hypoglycaemia, support the person to aim for an HbA1c level of 48 mmol mol(6.5percent).	
single drug	0	0.5370999999999999	2	For adults with type 2 diabetes managed either by lifestyle and diet, or by lifestyle and diet combined with a single drug not associated with hypoglycaemia, support the person to aim for an HbA1c level of 48 mmol mol(6.5percent).	In adults with type 2 diabetes, if HbA1c levels are not adequately controlled by a single drug and rise to 58 mmol mol (7.5percent) or higher: reinforce advice about diet, lifestyle and adherence to drug treatment and support the person to aim for an HbA1c level of 53 mmol mol (7.0percent) and intensify drug treatment.	
drug treatment	0	0.5060000000000001	9	For an adult with type 2 diabetes on antihypertensive drug treatment when diabetes is diagnosed, review blood pressure control and medications used.	Make changes only if there is poor control or if current drug treatment is not appropriate because of microvascular complications or metabolic problems.	Monitor blood pressure every 1–2 months, and intensify therapy if the person is already on antihypertensive drug treatment, until the blood pressure is consistently below 140 80 mmHg (below 130 80 mmHg if there is kidney, eye or cerebrovascular damage).	First-line antihypertensive drug treatment should be a once-daily, generic angiotensin-converting enzyme (ACE) inhibitor.	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	A calcium-channel blocker should be the first-line antihypertensive drug treatment for a woman for whom, after an informed discussion, it is agreed there is a possibility of her becoming pregnant	Check for possible adverse effects of antihypertensive drug treatment – including the risks from unnecessarily low blood pressure.	In adults with type 2 diabetes, if HbA1c levels are not adequately controlled by a single drug and rise to 58 mmol mol (7.5percent) or higher: reinforce advice about diet, lifestyle and adherence to drug treatment and support the person to aim for an HbA1c level of 53 mmol mol (7.0percent) and intensify drug treatment.	When using tricyclic drugs and antihypertensive drug treatments in adults with type 2 diabetes who have autonomic neuropathy, be aware of the increased likelihood of side effects such as orthostatic hypotension.	
cerebrovascular damage	0	0.5036	2	Add medications if lifestyle advice does not reduce blood pressure to below 140 80 mmHg (below 130 80 mmHg if there is kidney, eye or cerebrovascular damage).	Monitor blood pressure every 1–2 months, and intensify therapy if the person is already on antihypertensive drug treatment, until the blood pressure is consistently below 140 80 mmHg (below 130 80 mmHg if there is kidney, eye or cerebrovascular damage).	
insulin secretagogue	0	0.5911	1	Reducing the risk of hypoglycaemia should be a particular aim for a person using insulin or an insulin secretagogue.	
patient-education programme	0	0.5911	3	Ensure the patient-education programme provides the necessary resources to support the educators, and that educators are properly trained and given time to develop and maintain their skills.	Ensure that the patient-education programmes available meet the cultural, linguistic, cognitive and literacy needs within the local area.	Ensure that all members of the diabetes healthcare team are familiar with the patient-education programmes available locally, that these programmes are integrated with the rest of the care pathway, and that adults with type 2 diabetes and their family members or carers (as appropriate) have the opportunity to contribute to the design and provision of local programmes.	
care pathway	0	0.6607999999999999	1	Ensure that all members of the diabetes healthcare team are familiar with the patient-education programmes available locally, that these programmes are integrated with the rest of the care pathway, and that adults with type 2 diabetes and their family members or carers (as appropriate) have the opportunity to contribute to the design and provision of local programmes.	
diabetes healthcare	0	0.6607999999999999	1	Ensure that all members of the diabetes healthcare team are familiar with the patient-education programmes available locally, that these programmes are integrated with the rest of the care pathway, and that adults with type 2 diabetes and their family members or carers (as appropriate) have the opportunity to contribute to the design and provision of local programmes.	
healthcare team	0	0.6607999999999999	1	Ensure that all members of the diabetes healthcare team are familiar with the patient-education programmes available locally, that these programmes are integrated with the rest of the care pathway, and that adults with type 2 diabetes and their family members or carers (as appropriate) have the opportunity to contribute to the design and provision of local programmes.	
local programmes	0	0.6607999999999999	1	Ensure that all members of the diabetes healthcare team are familiar with the patient-education programmes available locally, that these programmes are integrated with the rest of the care pathway, and that adults with type 2 diabetes and their family members or carers (as appropriate) have the opportunity to contribute to the design and provision of local programmes.	
lifestyle advice	0	0.4646	3	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	Offer and reinforce preventive lifestyle advice.	Add medications if lifestyle advice does not reduce blood pressure to below 140 80 mmHg (below 130 80 mmHg if there is kidney, eye or cerebrovascular damage).	
education programme	0	0.612	5	Ensure that any structured education programme for adults with type 2 diabetes includes the following components: It is evidence-based, and suits the needs of the person. It has specific aims and learning objectives, and supports the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes. It has a structured curriculum that is theory-driven, evidence-based and resource-effective, has supporting materials, and is written down. It is delivered by trained educators who have an understanding of educational theory appropriate to the age and needs of the person, and who are trained and competent to deliver the principles and content of the programme. It is quality assured, and reviewed by trained, competent, independent assessors who measure it against criteria that ensure consistency. The outcomes are audited regularly.	Ensure the patient-education programme provides the necessary resources to support the educators, and that educators are properly trained and given time to develop and maintain their skills.	Offer group education programmes as the preferred option. Provide an alternative of equal standard for a person unable or unwilling to participate in group education.	Ensure that the patient-education programmes available meet the cultural, linguistic, cognitive and literacy needs within the local area.	Ensure that all members of the diabetes healthcare team are familiar with the patient-education programmes available locally, that these programmes are integrated with the rest of the care pathway, and that adults with type 2 diabetes and their family members or carers (as appropriate) have the opportunity to contribute to the design and provision of local programmes.	
educational theory	0	0.612	1	Ensure that any structured education programme for adults with type 2 diabetes includes the following components: It is evidence-based, and suits the needs of the person. It has specific aims and learning objectives, and supports the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes. It has a structured curriculum that is theory-driven, evidence-based and resource-effective, has supporting materials, and is written down. It is delivered by trained educators who have an understanding of educational theory appropriate to the age and needs of the person, and who are trained and competent to deliver the principles and content of the programme. It is quality assured, and reviewed by trained, competent, independent assessors who measure it against criteria that ensure consistency. The outcomes are audited regularly.	
independent assessors	0	0.612	1	Ensure that any structured education programme for adults with type 2 diabetes includes the following components: It is evidence-based, and suits the needs of the person. It has specific aims and learning objectives, and supports the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes. It has a structured curriculum that is theory-driven, evidence-based and resource-effective, has supporting materials, and is written down. It is delivered by trained educators who have an understanding of educational theory appropriate to the age and needs of the person, and who are trained and competent to deliver the principles and content of the programme. It is quality assured, and reviewed by trained, competent, independent assessors who measure it against criteria that ensure consistency. The outcomes are audited regularly.	
self-manage diabetes	0	0.612	1	Ensure that any structured education programme for adults with type 2 diabetes includes the following components: It is evidence-based, and suits the needs of the person. It has specific aims and learning objectives, and supports the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes. It has a structured curriculum that is theory-driven, evidence-based and resource-effective, has supporting materials, and is written down. It is delivered by trained educators who have an understanding of educational theory appropriate to the age and needs of the person, and who are trained and competent to deliver the principles and content of the programme. It is quality assured, and reviewed by trained, competent, independent assessors who measure it against criteria that ensure consistency. The outcomes are audited regularly.	
specific aims	0	0.612	1	Ensure that any structured education programme for adults with type 2 diabetes includes the following components: It is evidence-based, and suits the needs of the person. It has specific aims and learning objectives, and supports the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes. It has a structured curriculum that is theory-driven, evidence-based and resource-effective, has supporting materials, and is written down. It is delivered by trained educators who have an understanding of educational theory appropriate to the age and needs of the person, and who are trained and competent to deliver the principles and content of the programme. It is quality assured, and reviewed by trained, competent, independent assessors who measure it against criteria that ensure consistency. The outcomes are audited regularly.	
structured curriculum	0	0.612	1	Ensure that any structured education programme for adults with type 2 diabetes includes the following components: It is evidence-based, and suits the needs of the person. It has specific aims and learning objectives, and supports the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes. It has a structured curriculum that is theory-driven, evidence-based and resource-effective, has supporting materials, and is written down. It is delivered by trained educators who have an understanding of educational theory appropriate to the age and needs of the person, and who are trained and competent to deliver the principles and content of the programme. It is quality assured, and reviewed by trained, competent, independent assessors who measure it against criteria that ensure consistency. The outcomes are audited regularly.	
supporting materials	0	0.612	1	Ensure that any structured education programme for adults with type 2 diabetes includes the following components: It is evidence-based, and suits the needs of the person. It has specific aims and learning objectives, and supports the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes. It has a structured curriculum that is theory-driven, evidence-based and resource-effective, has supporting materials, and is written down. It is delivered by trained educators who have an understanding of educational theory appropriate to the age and needs of the person, and who are trained and competent to deliver the principles and content of the programme. It is quality assured, and reviewed by trained, competent, independent assessors who measure it against criteria that ensure consistency. The outcomes are audited regularly.	
trained educators	0	0.612	1	Ensure that any structured education programme for adults with type 2 diabetes includes the following components: It is evidence-based, and suits the needs of the person. It has specific aims and learning objectives, and supports the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes. It has a structured curriculum that is theory-driven, evidence-based and resource-effective, has supporting materials, and is written down. It is delivered by trained educators who have an understanding of educational theory appropriate to the age and needs of the person, and who are trained and competent to deliver the principles and content of the programme. It is quality assured, and reviewed by trained, competent, independent assessors who measure it against criteria that ensure consistency. The outcomes are audited regularly.	
1–2 months	0	0.5314	1	Monitor blood pressure every 1–2 months, and intensify therapy if the person is already on antihypertensive drug treatment, until the blood pressure is consistently below 140 80 mmHg (below 130 80 mmHg if there is kidney, eye or cerebrovascular damage).	
monitor blood	0	0.5314	1	Monitor blood pressure every 1–2 months, and intensify therapy if the person is already on antihypertensive drug treatment, until the blood pressure is consistently below 140 80 mmHg (below 130 80 mmHg if there is kidney, eye or cerebrovascular damage).	
advantageous metabolic	0	0.39970000000000006	1	Remember that lesser degrees of weight loss may still be of benefit, and that larger degrees of weight loss in the longer term will have advantageous metabolic impact.	
metabolic impact	0	0.39970000000000006	1	Remember that lesser degrees of weight loss may still be of benefit, and that larger degrees of weight loss in the longer term will have advantageous metabolic impact.	
hba1c levels	0	0.4915999999999999	1	In adults with type 2 diabetes, if HbA1c levels are not adequately controlled by a single drug and rise to 58 mmol mol (7.5percent) or higher: reinforce advice about diet, lifestyle and adherence to drug treatment and support the person to aim for an HbA1c level of 53 mmol mol (7.0percent) and intensify drug treatment.	
chronic kidney	0	0.36950000000000005	1	For guidance on managing kidney disease in adults with type 2 diabetes, see the NICE guideline on chronic kidney disease in adults.	
diabetic foot	0	0.36950000000000005	1	For guidance on preventing and managing foot problems in adults with type 2 diabetes, see the NICE guideline on diabetic foot problems.	
education programmes	1	0.3657	3	Offer group education programmes as the preferred option. Provide an alternative of equal standard for a person unable or unwilling to participate in group education.	Ensure that the patient-education programmes available meet the cultural, linguistic, cognitive and literacy needs within the local area.	Ensure that all members of the diabetes healthcare team are familiar with the patient-education programmes available locally, that these programmes are integrated with the rest of the care pathway, and that adults with type 2 diabetes and their family members or carers (as appropriate) have the opportunity to contribute to the design and provision of local programmes.	
equal standard	0	0.3657	1	Offer group education programmes as the preferred option. Provide an alternative of equal standard for a person unable or unwilling to participate in group education.	
offer group	0	0.3657	1	Offer group education programmes as the preferred option. Provide an alternative of equal standard for a person unable or unwilling to participate in group education.	
person unable	0	0.3657	1	Offer group education programmes as the preferred option. Provide an alternative of equal standard for a person unable or unwilling to participate in group education.	
preferred option	0	0.3657	1	Offer group education programmes as the preferred option. Provide an alternative of equal standard for a person unable or unwilling to participate in group education.	
visual acuity	0	0.21960000000000002	2	Perform visual acuity testing as a routine part of eye screening programmes.	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
excess weight	0	-0.040000000000000036	1	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	
harm reduction	0	-0.040000000000000036	1	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	
health services	1	-0.040000000000000036	1	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	
mental health	1	-0.040000000000000036	1	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	
nice guidelines	0	-0.040000000000000036	1	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	
smoking services	0	-0.040000000000000036	1	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	
weight gain	0	-0.040000000000000036	1	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	
weight management	0	-0.040000000000000036	1	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	
abnormalities multiple	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
blot haemorrhages	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
committee criteria	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
cotton wool	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
disc diameter	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
fovea circinate	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
intraretinal microvascular	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
microvascular abnormalities	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
national screening	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
optic disc	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
pre-proliferative retinopathy	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
referable maculopathy	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
referable pre-proliferative	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
retinal thickening	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
screening committee	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
sudden unexplained	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
temporal border	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
unexplained drop	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
venous beading	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
venous reduplication	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
wool spots	0	-1.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
